$71.4 Million is the total value of Foresite Capital Opportunity Management V, LLC's 10 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Pardes Biosciences Inc | $37,741,000 | -55.9% | 5,227,307 | 0.0% | 52.85% | -7.9% | ||
| QSI | Quantum-Si Incorporated | $7,479,000 | -40.5% | 1,598,125 | 0.0% | 10.47% | +24.2% | |
| Theseus Pharmaceuticals, Inc. | $5,405,000 | -9.1% | 468,820 | 0.0% | 7.57% | +89.9% | ||
| Sell | Cue Health Inc. | $4,138,000 | -79.8% | 641,483 | -58.0% | 5.79% | -57.8% | |
| CGEM | Sell | Cullinan Oncology, Inc. | $3,464,000 | -41.1% | 330,836 | -13.2% | 4.85% | +23.1% |
| ACET | Adicet Bio, Inc. | $3,395,000 | +14.2% | 170,000 | 0.0% | 4.75% | +138.5% | |
| GMTX | Gemini Therapeutics, Inc. | $3,385,000 | -52.2% | 2,435,125 | 0.0% | 4.74% | -0.2% | |
| KNTE | Kinnate Biopharma Inc. | $3,284,000 | -36.5% | 291,667 | 0.0% | 4.60% | +32.7% | |
| ENTA | New | Enanta Pharmaceuticals, Inc. | $1,619,000 | – | 22,750 | +100.0% | 2.27% | – |
| CMPX | Compass Therapeutics, Inc. | $1,507,000 | -56.8% | 1,100,000 | 0.0% | 2.11% | -9.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Pardes Biosciences Inc | 4 | Q3 2022 | 57.4% |
| Theseus Pharmaceuticals, Inc. | 4 | Q3 2022 | 16.7% |
| Gemini Therapeutics, Inc. | 4 | Q3 2022 | 12.0% |
| Quantum-Si Incorporated | 4 | Q3 2022 | 10.5% |
| Kinnate Biopharma Inc. | 4 | Q3 2022 | 10.5% |
| Compass Therapeutics, Inc. | 4 | Q3 2022 | 10.6% |
| Adicet Bio, Inc. | 4 | Q3 2022 | 7.3% |
| Enanta Pharmaceuticals, Inc. | 3 | Q3 2022 | 3.5% |
| Cue Health Inc. | 2 | Q1 2022 | 13.7% |
| Cullinan Oncology, Inc. | 2 | Q1 2022 | 4.8% |
View Foresite Capital Opportunity Management V, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 4 | 2023-08-31 |
| 4 | 2023-07-19 |
| 4 | 2023-05-10 |
| 4 | 2023-04-06 |
| 4 | 2023-02-22 |
| 4 | 2023-01-03 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 3 | 2022-06-13 |
View Foresite Capital Opportunity Management V, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.